Stable Isotope Labelled Compounds Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Stable Isotope Labelled Compounds Market - By Type (Deuterium, Carbon-12 & 13, Lithium- 6&7, Oxygen- 16&18, Chlorine- 35 & 37, Nitrogen-15), By Application (Research, Clinical Diagnostics, Industrial and Others), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centres, Academic & Research Institutes, and Other) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 198

Status: Published

Report Code: EMR100541

The global stable isotope labelled compounds market size is projected to reach USD 360 million by 2027 from USD 277.6 million in 2020, at a CAGR of 3.8 % between 2020 and 2027. Stable isotope-labelled compounds have generated considerable interest among researchers engaged in metabolism-mediated toxicity studies. Their role has risen in significance in assessment of in vivo metabolism in a vast range of metabolic research. The use of technologies such as mass spectrometry (MS) or nuclear magnetic resonance (NMR) has further expanded the research. These technologies have enabled researchers make better utilization of stable isotope labelled compounds for evaluating drugs’ disposition and their toxicity profile before they are used on patient populations. Their role has been rising in mechanistic toxicity studies as stable isotope-labelled compounds serve as a useful tool to enrich drug delivery research world over. Thus, they play a pivotal role in the management of several diseases, notably cancer and diabetes. Common stable isotope labelled compounds are 2H (Deuterium or D), 13C, 15N and 18O. Apart from metabolomics studies, stable isotope-labelled compounds are being increasingly used in environmental analysis, proteomics, and medical diagnostic research.

The report offers takes a critical and closer look at the current outlook and sheds light on emerging frontiers. The study findings are likely to form a useful guide for investors to identify lucrative avenues. The analyses of various growth dynamics in the stable isotope labelled compounds market helps emerging and established players to find out potential sources of revenue.

Rising body of research on the pharmaceutical and biotechnology industries is a key factor underpinning the rapid evolution of the stable isotope-labelled compounds market. In developed countries, investments in proteomics research have risen in recent years. Growing prevalence of various cancer types in several parts of the world is a key factor bolstering the demand for stable isotope-labelled compounds. Moreover, various drug toxicity studies have risen in volumes with the aim of developing effective therapeutics and diagnostics. Numerous emerging markets have been attractive sizeable investments in pharmaceutical research and development. Moreover, the high cost of stable isotope-labelled compounds may be a deterrent factor crippling the market prospects. Moreover, there is paucity of technical expertise for conducting pharmaceutical and biomedical research using stable isotope-labelled compounds.

Stable isotope-labelled compounds hold a large, promising potential in dynamic assessment of vivo metabolism in the paediatric population. Rising focus on accelerating the validation of new treatment modalities in order to reduce morbidity and mortality in pediatric populations is a key trend boosting the market.

The prominent players in the stable isotope labelled compounds market include PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel). Major players have focused on acquisitions, product launches, agreements, and partnerships to increase their shares in the global market.

Cambridge Isotope Laboratories (CIL) is one of the leading positions in the stable isotope-labelled compounds market. The company offers a comprehensive portfolio of stable isotope-labelled compounds for laboratories; medical, government, and academic research centers; and healthcare facilities. The company offers more than 15,000 products and has ISO 13485, ISO/IEC 17025, and ISO Guide 34 quality systems, along with cGMP production capabilities. Over the years, the company has extended its global footprint in four countries—the US, Canada, France, and Germany.

Analyst Commentary

The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labelled compounds is expected to restrain the growth of this market during the forecast period.

Based on end-users, ,the pharmaceutical and biotechnology companies segment accounted for the larger share of the market in 2018. The growth of the pharmaceutical & biotechnology segment is attributed to the increase in R&D spending, which will drive drug research activities in the industry.
On the basis of type, he deuterium segment is dominating the global stable isotope labelled compound market as It is used by the mostly toxicologist and metabolism scientist so as to identify its major role in targeting organ toxicities and drugs disposition. Other reason which made many lab technicians to follow this as it is easiest to introduce into any molecule and is considered to be cheapest amongst all isotopes.

Segmentation

The global stable isotope labelled compounds market is segmented on the basis of type, application, end user and region. Based on end-users, the stable isotope labelled compounds market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic centers, academic & research institutes, and other end users.On the basis of type, the market is segmented into deuterium, carbon-12 & 13, lithium- 6&7, oxygen- 16&18, chlorine- 35 & 37, nitrogen-15..On the basis of application, the market is segmented into research, clinical diagnostics, industrial and others.

Regional Analysis

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of cancer in the region, established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.

The growth in these regions is fueled by rapid advances in nutrition and metabolic research. Particularly, in the U.S., stable isotope-labelled compounds are witnessing large-scale production. In Canada, surging demand for stable isotope-labelled compounds is increasingly propped by advances being made in positron emission tomography technique. Developed regions are also likely to hold vast potential in the next few years. Presence of a few globally prominent players in North America who conduct extensive quality testing for these compounds reinforces large revenue potential of the region.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Types
2.3.1. Secondary Types
2.3.1.1. Preliminary data mining
2.3.2. Primary Types
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Engine Powered of Suppliers
3.7.2. Bargaining Engine Powered of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Stable Isotope Labelled Compounds Market
Chapter 5. Global Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
5.1. Global Stable Isotope Labelled Compounds Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Deuterium
5.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Carbon 12-13
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Lithium-6&7
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Oxygen-16&18
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.5. Chlorine-35&37
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.6. Nitrogen-15
5.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
6.1. Global Stable Isotope Labelled Compounds Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Research
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Clinical Diagnostic
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Industrials
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Others
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Stable Isotope Labelled Compounds Market Overview, By end user, 2015 - 2027 (USD Million)
7.1. Global Stable Isotope Labelled Compounds Market Share, By End user, 2015 - 2027 (USD Million)
7.1.1. Pharmaceutical & biotechnological companies
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Hospitals & diagnostic centres
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Academic & research institutes
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Stable Isotope Labelled Compounds Market Overview, By Geography, 2015 - 2027 (USD Million)
8.1. Global Stable Isotope Labelled Compounds Market Share, By Geography, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 & 2027 (%)
Chapter 9. North America Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. North America Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. North America Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. North America Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. North America Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. U.S. Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. U.S. Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.1.3. Other Segments
9.1.4.2. Canada Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. Canada Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.2.3. Other Segments
9.1.4.3. Mexico Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. Mexico Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.4.3.3. Other Segments
Chapter 10. Europe Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Europe Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Stable Isotope Labelled Compounds Market Overview, By Types, 2015 - 2027 (USD Million)
10.1.3. Europe Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Europe Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. Germany
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. Germany Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.1.3. Others Segments
10.1.4.2. France
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.2.2. France Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.2.3. Others Segments
10.1.4.3. UK
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. UK Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.3.3. Others Segments
10.1.4.4. Italy
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.4.2. Italy Stable Isotope Labelled Compounds Market Overview, By Type 2015 - 2027 (USD Million)
10.1.4.4.3. Others Segments
10.1.4.5. Spain
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Spain Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.5.3. Others Segments
10.1.4.6. Rest of Europe
10.1.4.6.1. Market size and projections, 2015 – 2025
10.1.4.6.2. Rest of Europe Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.4.6.3. Others Segments
Chapter 11. Asia Pacific Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Stable Isotope Labelled Compounds Market Overview, By Types, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. India
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. India Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. Other Segments
11.1.4.2. China
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. China Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. Other Segments
11.1.4.3. Japan
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Japan Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Other Segments
11.1.4.4. South Korea
11.1.4.4.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.4.2. South Korea Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.4.3. Other Segments
11.1.4.5. Rest of Asia Pacific
11.1.4.5.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.4.5.2. Rest of Asia Pacific Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.5.3. Other Segments
Chapter 12. Middle East & Africa Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Stable Isotope Labelled Compounds Market Overview, By Types, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.4.1. GCC
12.1.4.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.1.2. GCC Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.1.3. Other Segments
12.1.4.2. South Africa
12.1.4.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.2.2. South Africa Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.2.3. Other Segments
12.1.4.3. Rest of Middle East & Africa
12.1.4.3.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.4.3.2. Rest of Middle East & Africa Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4.3.3. Other Segments
Chapter 13. South America Stable Isotope Labelled Compounds Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Stable Isotope Labelled Compounds Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.2. South America Stable Isotope Labelled Compounds Market Overview, By Types, 2015 - 2027 (USD Million)
13.1.3. South America Stable Isotope Labelled Compounds Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.4. South America Stable Isotope Labelled Compounds Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.5. Brazil
13.1.5.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.5.2. Brazil Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.5.3. Other Segments
13.1.6. Argentina
13.1.6.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.6.2. Argentina Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.6.3. Other Segments
13.1.7. Rest of South America
13.1.7.1. Market size and projections, 2015 – 2027
13.1.7.2. Rest of South America Stable Isotope Labelled Compounds Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.7.3. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Distribution channel development
Chapter 15. Key Vendor Analysis
15.1. PerkinElmer
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Distribution channel Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Cambridge Isotope Lboratories
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Distribution channel Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. URENCO Limited
15.4. Medical Isotopes
15.5. Trace Science International
Chapter 16. Stable Isotope Labelled Compounds Market Cost Analysis
16.1. Stable Isotope Labelled Compounds Market Key Raw Material Analysis
16.1.1. Key Raw Material
16.1.2. Price Trend of Key Raw Material
16.1.3. Key Suppliers of Raw Material
16.1.4. Market Concentration Rate of Raw Material
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Stable Isotope Labelled Compounds Market Industrial Chain Analysis
17.2. Upstream Raw Material Sourcing
17.3. Raw Material Type of Stable Isotope Labelled Compounds Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Distribution channel
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Engine Powered of Suppliers
5. Engine Powered of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Stable Isotope Labelled Compounds Market share, By Types, 2020 & 2027 (%)
10. Global Stable Isotope Labelled Compounds Market share, by Deuterium, By Types, 2020 & 2027 (USD Million)
11. Global Stable Isotope Labelled Compounds Market share, by Carbon 12-13, By Types, 2020 & 2027 (USD Million)
12. Global Stable Isotope Labelled Compounds Market share, By Lithium-6&7, By Types 2020 & 2027 (USD Million)
13. Global Stable Isotope Labelled Compounds Market share, By Oxygen-16&18, By Types 2020 & 2027 (USD Million)
14. Global Stable Isotope Labelled Compounds Market share, By Chlorine-35&37, By Types 2020 & 2027 (USD Million)
15. Global Stable Isotope Labelled Compounds Market share, By Nitrogen-15, By Types 2020 & 2027 (USD Million)
16. Global Stable Isotope Labelled Compounds Market share, By Application, 2020 & 2027 (%)
17. Global Stable Isotope Labelled Compounds Market share, by Clinical Diagnostic , By Application, 2020 & 2027 (USD Million)
18. Global Stable Isotope Labelled Compounds Market share, by Research, By Application, 2020 & 2027 (USD Million)
19. Global Stable Isotope Labelled Compounds Market share, by Clinical Diagnostic , By Application, 2020 & 2027 (USD Million)
20. Global Stable Isotope Labelled Compounds Market share, by Industrials, By Application, 2020 & 2027 (USD Million)
21. Global Stable Isotope Labelled Compounds Market share, by Others, By Application, 2020 & 2027 (USD Million)
22. Global Stable Isotope Labelled Compounds Market share, By End User, 2020 & 2027 (%)
23. Global Stable Isotope Labelled Compounds Market share, by pharmaceutical & biotechnology companies, By End User, 2020 & 2027 (USD Million)
24. Global Stable Isotope Labelled Compounds Market share, by hospitals & diagnostic centres, By End User, 2020 & 2027 (USD Million)
25. Global Stable Isotope Labelled Compounds Market share, by academic & research institutes, By End User, 2020 & 2027 (USD Million)
26. North America Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
27. North America Stable Isotope Labelled Compounds Market share, by Countries, 2020 & 2027 (%)
28. U.S. Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
29. Canada Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
30. Europe Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
31. Europe Stable Isotope Labelled Compounds Market share, by Countries, 2020 & 2027 (%)
32. Spain Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
33. UK Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
34. Italy Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
35. Germany Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
36. France Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
37. Rest of Europe Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
38. Asia-Pacific Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
39. Asia-Pacific Stable Isotope Labelled Compounds Market share, by Countries, 2020 & 2027 (%)
40. China Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
41. India Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
42. Australia Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
43. Japan Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
44. Rest of Asia-Pacific Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
45. Middle East & Africa Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
46. Middle East & Africa Stable Isotope Labelled Compounds Market share, by Countries, 2020 & 2027 (%)
47. GCC Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
48. South Africa Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
49. Rest Of Middle East & Africa Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
50. South America Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
51. Brazil Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
52. Mexico Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
53. Argentina Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)
54. Rest Of South America Stable Isotope Labelled Compounds Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Stable Isotope Labelled Compounds Market, 2020-2027 (USD Million)
4. Stable Isotope Labelled Compounds requirement, by country, 2020-2027, (USD Million)
5. North America Stable Isotope Labelled Compounds Market, By Type, 2020-2027 (USD Million)
6. North America Stable Isotope Labelled Compounds Market, By Application, 2020-2027 (USD Million)
7. Europe Stable Isotope Labelled Compounds Market, By Types, 2020-2027 (USD Million)
8. Europe Stable Isotope Labelled Compounds Market, By Application, 2020-2027 (USD Million)
9. Asia Pacific Stable Isotope Labelled Compounds Market, By Types, 2020-2027 (USD Million)
10. Asia Pacific Stable Isotope Labelled Compounds Market, By Application, 2020-2027 (USD Million)
11. Middle East & Africa Stable Isotope Labelled Compounds Market, By Types, 2020-2027 (USD Million)
12. Middle East & Africa Stable Isotope Labelled Compounds Market, By Application, 2020-2027 (USD Million)
13. South America Stable Isotope Labelled Compounds Market, By Types, 2020-2027 (USD Million)
14. South America Stable Isotope Labelled Compounds Market, By Application, 2020-2027 (USD Million)
15. Global Stable Isotope Labelled Compounds Market, Company Market Share, 2020 & 2027(%)
16. PerkinElmer: Product Benchmarking
17. URENCO Limited.: Financial Performance
18. Medical isotopes Inc.: Product Benchmarking
19. Alsachim Inc..: Financial Performance
20. Rotem Industries: Product Benchmarking
21. IsoSciences LLC: Financial Performance
22. Omincron Biochemicals: Product Benchmarking
23. Merck KgaA (Germany): Financial Performance

The Leading Key Players in Stable Isotope Labelled Compounds Market

PerkinElmer Inc. (US)
Merck KGaA (Germany)
Cambridge Isotope Laboratories Inc. (US)
URENCO Limited (UK)
IsoSciences
LLC (US)
Medical Isotopes Inc. (US)
Omicron Biochemicals Inc. (US)
Trace Sciences International (US)
Alsachim (France)
Taiyo Nippon Sanso Corporation (Japan)
Rotem Industries Israel Ltd. (Israel).